LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$3.19
−3.04%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-62.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 30, 2025 | Carle Vanessa · officer: Secretary | Purchase | 750 | $0.91 |
| Jul 30, 2025 | DOCHERTY JOHN MARTIN · director, officer: President & CSO | Purchase | 5,376 | $0.93 |
| Jul 30, 2025 | CHRISTOPHER RICHARD · director, officer: Chief Executive Officer | Purchase | 15,000 | $0.91 |
| Jul 30, 2025 | BUNKA CHRISTOPHER · director | Purchase | 11,900 | $0.91 |
| Jul 30, 2025 | BUNKA CHRISTOPHER · director | Purchase | 15,600 | $0.92 |
| Jul 30, 2025 | McKechnie William Edward · director | Purchase | 5,000 | $0.91 |
| May 16, 2025 | Baxter Nicholas W · director | A-Award | 11,000 | $1.04 |
| May 16, 2025 | DOCHERTY JOHN MARTIN · director, officer: President | A-Award | 150,000 | $1.04 |
| May 16, 2025 | Bhullar Baljinder · director | A-Award | 11,000 | $1.04 |
| May 16, 2025 | Carle Vanessa · officer: Secretary | A-Award | 15,000 | $1.04 |
| May 16, 2025 | BUNKA CHRISTOPHER · director | A-Award | 11,000 | $1.04 |
| May 16, 2025 | Shankman Michael Elliot · officer: Chief Financial Officer | A-Award | 50,000 | $1.04 |
| May 16, 2025 | REESE ALBERT L JR · director | A-Award | 11,000 | $1.04 |
| May 16, 2025 | CHRISTOPHER RICHARD · director, officer: Chief Executive Officer | A-Award | 150,000 | $1.04 |
| Jan 10, 2025 | BUNKA CHRISTOPHER · director | A-Award | 100,000 | $0.00 |
| Dec 3, 2024 | CHRISTOPHER RICHARD · officer: Chief Executive Officer | Purchase | 22,828 | $2.24 |
| Dec 3, 2024 | CHRISTOPHER RICHARD · officer: Chief Executive Officer | Purchase | 27,172 | $2.47 |
| Aug 13, 2024 | TURKEL CATHERINE C. · director | Purchase | 1,600 | $3.13 |
| Aug 1, 2024 | Carle Vanessa · officer: Secretary | Sale | 2,567 | $4.00 |
| Jul 30, 2024 | McKechnie William Edward · director | A-Award | 12,000 | $3.39 |
| Jul 30, 2024 | Baxter Nicholas W · director | A-Award | 12,000 | $3.39 |
| Jul 30, 2024 | TURKEL CATHERINE C. · director | A-Award | 12,000 | $3.39 |
| Jul 30, 2024 | REESE ALBERT L JR · director | A-Award | 12,000 | $3.39 |
| May 15, 2024 | Carle Vanessa · officer: Secretary | M-Exempt | 2,500 | $1.15 |
| May 10, 2024 | REESE ALBERT L JR · director | A-Award | 5,000 | $2.36 |
| May 10, 2024 | Baxter Nicholas W · director | A-Award | 5,000 | $2.36 |
| May 10, 2024 | McKechnie William Edward · director | A-Award | 5,000 | $2.36 |
| May 10, 2024 | Carle Vanessa · officer: Secretary | A-Award | 10,000 | $2.36 |
| May 10, 2024 | TURKEL CATHERINE C. · director | A-Award | 5,000 | $2.36 |
| May 10, 2024 | BUNKA CHRISTOPHER · director, officer: Chief Executive Officer | A-Award | 49,500 | $2.36 |
Institutional positioning
13F filings over the trailing two quarters
New 16Increased 12Reduced 14Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| INVENOMIC CAPITAL MANAGEMENT LP | Reduced | 442,301 | May 15, 2026 |
| Invenomic Capital Management LP | Reduced | 345,685 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 298,436 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 294,157 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 250,415 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 222,293 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 156,945 | Sep 2, 2026 |
| TORONTO DOMINION BANK | Unchanged | 140,013 | May 15, 2026 |
| TORONTO DOMINION BANK | Reduced | 100,013 | Aug 14, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 94,166 | May 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 94,166 | Aug 13, 2026 |
| HRT FINANCIAL LP | Increased | 65,049 | Aug 14, 2026 |
| UBS GROUP AG | Reduced | 52,708 | May 5, 2026 |
| UBS Group AG | Reduced | 46,966 | Aug 13, 2026 |
| NORTHERN TRUST CORP | Increased | 39,825 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 30, 2025